Gene editing may enhance CAR T-cell therapy for hematologic malignancies

Researchers at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis have used gene editing technology known as CRISPR to engineer human T cells to attack certain cancers. Results from studies conducted …

Date : 2018-07-17T20:39:00.000Z
Source :

Leave a Comment